Target intelligence / Profile preview

Leishmania 16S ribosomal RNA (16S rRNA)

Target
16S rRNA
Molecular classification
Other (ribosomal RNA, ribosome component)
01

Overview

Leishmania 16S ribosomal RNA is a structural RNA component of the small (SSU) ribosomal subunit in Leishmania species, analogous to the bacterial 16S rRNA, and critical for ribosome function and protein synthesis. In Leishmania mitochondria, this is referred to as 9S rRNA, preserving the characteristic four-domain secondary structure of the bacterial 16S rRNA, albeit in a minimized form. It forms the decoding site essential for interaction with mRNA and tRNAs during translation. The structure and sequence of Leishmania 16S rRNA are distinct from both bacterial and other eukaryotic counterparts, which may impact susceptibility to ribosome-targeting antibiotics and explain unique features of Leishmania translational regulation. Paromomycin, an aminoglycoside, can bind to the decoding site of Leishmania 16S rRNA, leading to inhibition of protein synthesis and parasite death, making the 16S rRNA a validated antileishmanial drug target.

Other names
small subunit ribosomal RNA9S rRNA (in Leishmania mitochondria)SSU rRNA
02

Mechanism of action

Aminoglycoside antibiotics (such as paromomycin) bind to the A-site in helix 44 of the 16S rRNA in the small ribosomal subunit, interfering with the accuracy of mRNA decoding and causing protein mistranslation, which results in antiprotozoal activity

03

Biological functions

TranslationProtein synthesisRibosome assembly
04

Disease associations

Infection (Leishmaniasis)
05

Safety considerations

Drug selectivity (potential for eukaryotic ribosome inhibition)Emergence of resistance due to rRNA mutationsOff-target toxicity with aminoglycoside antibiotics
06

Interacting drugs

paromomycin

Beyond the preview

Go deeper on Leishmania 16S ribosomal RNA (16S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leishmania 16S ribosomal RNA (16S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call